News

Filter

Current filters:

None

82 to 91 of 98144 results

Eli Lilly collaborates with Hanmi on BTK inhibitor

19-03-2015

US pharma major Eli Lilly and South Korean drugmaker Hanmi Pharmaceutical have entered into an exclusive…

Anti-Arthritics/RheumaticsEli LillyHanmi PharmaceuticalImmunologicalsLicensingPharmaceutical

Amicus has positive meeting with EMA and FDA to accelerate approval of Fabry monotherapy

Amicus has positive meeting with EMA and FDA to accelerate approval of Fabry monotherapy

19-03-2015

Amicus Therapeutics has had positive meetings with regulatory authorities in Europe and the USA to discuss…

Amicus TherapeuticsBiotechnologyEuropemigalastatRare diseasesRegulationUSA

Kite Pharma acquires T-Cell Factory for $21 million upfront

19-03-2015

US oncology biopharma specialist Kite Pharma has further strengthened its TCR product platform and established…

BiotechnologyKite PharmaMergers & AcquisitionsT-Cell Factory

Zealand Pharma makes organizational reshuffle, splitting research and development

Zealand Pharma makes organizational reshuffle, splitting research and development

19-03-2015

Danish company Zealand Pharma is to make organizational and management changes, including splitting research…

Adam SteensbergBoardroomBusiness FinanceDenmarkPharmaceuticalTechnology InternetZealand Pharma

Pharma and biotech M&A deals reached record $212 billion in 2014

Pharma and biotech M&A deals reached record $212 billion in 2014

19-03-2015

Despite a slight wobble in the spring, the pharma and biotech sector came back stronger than ever in…

BiotechnologyFinancialGlobalMergers & AcquisitionsPharmaceutical

Global pharma has economic footprint equivalent to that of Argentina, says IFPMA report

Global pharma has economic footprint equivalent to that of Argentina, says IFPMA report

19-03-2015

The global pharma industry has a total economic footprint of $437 billion in terms of gross value added,…

Daiichi SankyoFinancialIFPMAPharmaceuticalWifOR

AbbVie and C2N ink global license deal for Alzheimer's disease therapy

AbbVie and C2N ink global license deal for Alzheimer's disease therapy

19-03-2015

US drugmaker AbbVie has entered into an exclusive worldwide license agreement with C2N Diagnostics, a…

AbbVieBiotechnologyC2N DiagnosticsGlobalLicensingNeurological

AstraZeneca to co-commercialize Movantik with Daiichi Sankyo in USA

AstraZeneca to co-commercialize Movantik with Daiichi Sankyo in USA

19-03-2015

Anglo-Swedish pharma major AstraZeneca has inked a deal with Japanese peer Daiichi Sankyo for the co-commercialization…

AstraZenecaDaiichi SankyoGastro-intestinalsMarkets & MarketingMovantikPharmaceuticalUSA

Nektar Therapeutics stock falls as NKTR-102 fails Phase III breast cancer study

Nektar Therapeutics stock falls as NKTR-102 fails Phase III breast cancer study

19-03-2015

Nektar Therapeutics has announced that its Phase III study of NKTR-102 (etirinotecan pegol) in advanced…

Nektar TherapeuticsNKTR-102OncologyPharmaceuticalResearch

82 to 91 of 98144 results

Back to top